NEW YORK (GenomeWeb News) - Molecular diagnostics company Gene Security Network has raised around $4 million in Series A financing, the firm said yesterday.
The round of venture funding was led by Claremont Creek Ventures and included investments from Sequoia Capital, Huntington Reproductive Center, and private investor Marissa Mayer, who is VP of search products and user experience at Google, with a focus on Google Health.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.